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Since HIV-1 has a propensity to integrate into actively expressed genes, transcriptional interference from
neighboring host promoters has been proposed to contribute to the establishment and maintenance HIV-
1 latency. To gain insights into how endogenous promoters inﬂuence HIV-1 transcription we utilized a
set of inducible T cell lines and characterized whether there were correlations between expression of
endogenous genes, provirus and long terminal repeat architecture. We show that neighboring promoters
are active but have minimal impact on HIV-1 transcription, in particular, expression of the endogenous
gene did not prevent expression of HIV-1 following induction of latent provirus. We also demonstrate
that releasing paused RNAP II by diminishing negative elongation factor (NELF) is sufﬁcient to reactivate
transcriptionally repressed HIV-1 provirus regardless of the integration site and orientation of the pro-
virus suggesting that NELF-mediated RNAP II pausing is a common mechanism of maintaining HIV-1
latency.
& 2015 Elsevier Inc. All rights reserved.Introduction
In patients undergoing anti-retroviral therapy, a dynamic
population of HIV-1 infected cells persists and is mobilized to
contribute to robust viral replication and spread upon treatment
interruption (Bruner et al., 2015; Dahabieh et al., 2015). Since these
latently infected cells present a major challenge to curing HIV
infection, there is interest in understanding the biochemical
mechanisms responsible for establishing, maintaining and reacti-
vating transcriptionally repressed HIV-1 provirus. Studies with cell
lines and primary cells have suggested that multiple mechanisms
are responsible for the transcriptional repression that promotes
HIV-1 latency. Some of the mechanisms that have been implicated
in limiting HIV-1 transcription and contributing to the establish-
ment of latency include RNA polymerase II (RNAP II) pausing,ction of Infectious Diseases,
treet, 645 EBRC, Boston, MA
Henderson).chromatin structure, recruitment of transcriptional repressor
complexes and silencing by non-coding RNAs (Mbonye and Karn,
2014; Schiralli Lester and Henderson, 2012).
With approximately 70% of HIV-1 integrated into introns of
actively transcribed host genes (Ding et al., 2013; Han et al., 2004;
Lenasi et al., 2008; Lewinski et al., 2005; Rezaei and Cameron,
2015; Shan et al., 2011; Sherrill-Mix et al., 2013) it has been pro-
posed that neighboring promoters transcriptionally interfere with
the HIV-1 long terminal repeat (LTR) to repress proviral tran-
scription. Whether a neighboring promoter inﬂuences HIV tran-
scription may depend on the orientation of the two promoters,
displacement or competition for the transcriptional machinery
and transcriptional activators, local chromatin organization, or
collisions between two active RNAP II complexes (Greger et al.,
1998; Lenasi et al., 2008). Although transcriptional interference
has been implicated as a mechanism of HIV-1 latency (Gallastegui
et al., 2011; Greger et al., 1998; Lenasi et al., 2008), whether there
are common biochemical mechanisms by which a neighboring
promoter represses HIV-1 provirus has not been addressed.
K. Kaczmarek Michaels et al. / Virology 486 (2015) 7–148To investigate the inﬂuence of proximal host promoters on
HIV-1 transcription, we examined the induction of HIV-1 in three
different latently infected cell lines in which the integration sites
have been mapped. We demonstrate that transcription of host
genes does not exclude transcription from a proximally integrated
HIV-1 LTR, and that a common regulatory check point shared by
these cell lines regardless of orientation of the HIV-1 provirus is
RNAP II processiveness.Results
Characterization of proviral integration sites in HIV-1 inducible cell
lines
To gain insights into mechanisms by which neighboring
endogenous promoters inﬂuence HIV-1 transcription, we utilized
three previously characterized T cell lines which harbor latent HIV-
1-GFP provirus, CA5, BA1, and 11B10 (Duverger et al., 2009; Jones
et al., 2007). The proviral integration sites were mapped and
sequenced for these three lines and the orientation of the provirus
relative to the endogenous genes were determined (Fig. 1). CA5
cells have provirus integrated in the exon of RNA binding motif
protein 12 (RBM12) in a parallel orientation (Fig. 1). RBM12 has
been implicated in meibomian cell carcinoma (Kumar et al., 2007)
and shares a promoter and 5’exon with copine I (CPNE1) (Yang
et al., 2008). The function of RBM12 remains unidentiﬁed, while
CPNE1 plays role in cell-cycle and proliferation (Skawran et al.,
2008). In BA1 cells, HIV-1 is integrated in the intron of PDZ domain
containing 8 (PDZD8) in a convergent orientation (Fig. 1). PDZD8 is
a cytoskeleton-regulating protein which was recently shown to
bind HIV-1 Gag, stabilizing capsid and enhancing HIV reverse
transcription (Guth and Sodroski, 2014; Henning et al., 2010). HIV-
1 is inserted in the intron of HELZ in a convergent orientation in
the 11B10 cells (Fig. 1). HELZ is a zinc-ﬁnger containing RNA-
helicase important for global translational initiation (Hasgall et al.,
2011). We examined 17 cell lines and did not ﬁnd any examples of
the HIV-1 LTR integrating in a divergent orientation relative to an
endogenous promoter.Fig. 1. Proviral Integration Sites in CA5, BA1 and 11B10. Summary and schematic of H
infected T cell lines. Sequencing is described in Materials and methods. The lengths of th
of provirus are indicated.We examined the expression of these genes in the T cell lines
using quantitative real time PCR to determine their normal
expression pattern and whether HIV-1 might alter their expres-
sion. All three genes are expressed in Jurkat cells and the process
of HIV-1 infection and selection of the cells, in general, only had a
modest impact on the baseline expression of the host genes in
which the virus integrated into (Fig. 2A). Speciﬁcally, RMB12
expression was not affected in any of the cell lines including CA5,
the cell line in which the provirus is integrated into this gene
(Fig. 2). Integration of provirus into PDZD8 and HELZ genes
increased their expression; PDZD8 was enhanced by 3 fold in BA1
cells and HELZ was expressed 3.5 fold more in 11B10 (Fig. 2A).
Since increased expression of PDZD8 and HELZ was not observed
in all cell lines, this may reﬂect functional interactions between
the endogenous promoters and the integrated HIV-1 proviral LTRs.
We also assessed the expression of these genes following T cell
activation. Cells lines were induced by treating with PMAþPHA for
24 h and mRNAs were measured by real-time PCR. Consistent with
previous reports (Duverger et al., 2009), PMAþPHA induced
robust HIV-1 expression in all three lines (Fig. 2C). The ability to
strongly induce HIV-1 transcription in these cell lines was not
inﬂuenced by the orientation of the provirus relative to the
endogenous gene since all three lines robustly expressed HIV-1
(Fig. 2C). None of the three genes were inducible in any of the cell
lines (Fig. 2A). Based on endogenous levels of RBM12, PDZD8 and
HELZ in Jurkat cells and cell lines in which HIV-1 provirus is not
integrated into the host gene HIV-1 infection itself did not affect
host gene expression (Fig. 2A). Furthermore, with the exception of
11B10 in which the HELZ gene was decreased by greater than 90%
following PMAþPHA treatment, induction of HIV-1 expression did
not require signiﬁcant repression of the genes which harbored the
provirus (Fig. 2A) suggesting that expression of the endogenous
gene does not necessarily exclude expression of HIV-1. To assure
that integration did not inactivate the endogenous promoters we
used RT-quantitative PCR to detect RNAs that included HIV and
host RNA sequences. These chimeric transcripts were detected in
all three cell lines.IV-1 provirus integration sites relative to neighboring host promoter for latently
e endogenous host gene, as well as its position on chromosome and integration site
Fig. 2. Activation of latent cells results in altered host gene expression. Uninfected Jurkat T cells as well as CA5, BA1 and 11B10 cells were treated with 2 μg/mL PHA and
10 ng/mL PMA for 24 h. (A) Expression of the neighboring host gene mRNAs was measured by qRT-PCR and normalized to β-actin. (B) Expression of chimeric RNA was
ampliﬁed by RT-PCR and PCR products were visualized on 1% agarose gel. (C) Expression of elongated HIV-1 mRNAs was measured by qRT-PCR and normalized to β-actin.
These data are from a single experiment performed in triplicate and are representative of three independent experiments. Bars show average values 7SD, n¼3. npo0.05,
nnpo0.01 and nnnpo0.001 (Student's t test).
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To explore the molecular mechanisms that are contributing to
the repression of HIV-1 provirus integrated into actively expressed
endogenous genes we initially inhibited histone deacetylases
(HDACs) to determine whether this induces HIV-1 expression in
the cell lines. HDACs, by regulating chromatin organization
through removing acetyl groups from histones, have been impli-
cated as a primary mechanism that limits HIV-1 transcription and
contributes to HIV-1 latency. Cells were treated with PMAþPHA or
Trichostatin A (TSA), a general inhibitor of class I and II HDACs and
a potent inducer of HIV-1 transcription (Van Lint et al., 1996). We
examined the induction of HIV-1 transcription by monitoring GFP
expression via ﬂow cytometry in the different cell lines (Fig. 3).
PMAþPHA treatment induced HIV-1 expression in more than 65%
cells as measured by GFP expression (Fig. 3B). Overall, treatment
with TSA was not as effective as treatment with PMAþPHA at
inducing HIV-1 expression (Fig. 3B). TSA treatment differentially
reactivated HIV-1 and a robust induction of HIV-1 expression
following TSA treatment was only observed in 11B10 cells (Fig. 3).
Induction of HIV-1 in BA1 and CA5 cells by TSA was 70% less
efﬁcient than induction seen with PMAþPHA treatment (Fig. 3B).
We conﬁrmed that all three cell lines were responsive to TSA by
measuring global changes in acetylated histone H3 (AcH3) by
immunoblots (Fig. 3C). Since these lines represent cells that have
proviruses integrated in converse (BA1, 11B10) and parallel (CA5)
orientations the integration orientation does not impose a speciﬁc
sensitivity to HDAC inhibitors. Overall, these data suggest that
chromatin organization is not a general mechanism of repression
in these cell lines which is consistent with HIV-1 integrating into
transcriptionally active genes with an open chromatin structure.RNAP II pausing has been suggested to be a critical checkpoint
for HIV-1 transcription and we examined if transcriptional elon-
gation was a limiting step in these latent cell lines. RNAP II pausing
is characterized by accumulation of RNAP II and NELF, which is
necessary for pausing, at the transcriptionally repressed LTR
(Jadlowsky et al., 2014; Peterlin and Price, 2006; Zhang et al.,
2007). We performed chromatin immunoprecipitation assays
(ChIPs) to assess whether RNAP II and NELF were associated with
the integrated proviruses. RNAP II and NELF were detected at the
HIV-1 LTR consistent with RNAP II pausing (Fig. 4). Furthermore,
we observed the presence of AcH3 at the LTR in CA5 and BA1 cells
(Fig. 4) suggesting open chromatin in these cells which is also
consistent with the minimal proviral induction seen in TSA treated
cells (Fig. 3). 11B10 cells had low levels of AcH3 at the 5’ LTR
(Fig. 4), which could explain why 11B10 cells were more sensitive
to TSA treatment (Fig. 3). RNAP II pausing is associated with the
accumulation of initiated HIV-1 mRNAs relative to full length HIV-
1 mRNAs (Natarajan et al., 2013). We used quantitative real time
(RT) PCR to determine the ratio of initiated to elongated HIV-1
mRNA (Natarajan et al., 2013). In all three cell lines, the ratio of
initiated transcripts was 3–10 fold higher than elongated HIV-1
mRNA prior to cell activation (Fig. 5). Upon treatment with
PMAþPHA, we observed robust HIV-1 transcription and a shift in
the ratio of initiated to elongated transcripts that approached
1 suggesting a release in paused RNAP II (Fig. 5).
These above data suggest that RNAP II may be a common
checkpoint limiting HIV-1 transcription in the different cell lines
regardless of integration sites and orientation. It has been pre-
viously demonstrated by our group and others that targeting NELF
releases paused RNAP II from the HIV-1 promoter and induces
HIV-1 transcription (Jadlowsky et al., 2014; Natarajan et al., 2013;
Zhang et al., 2007). To formally test if RNAP II pausing is limiting
Fig. 3. Provirus integration site affects reactivation rate of latent HIV-1. Cell lines were treated with 2 μg/mL PHA and 10 ng/mL PMA or 0.5 μM TSA for 24 h. (A) GFP
expression was measured by ﬂow cytometry. (B) Data represent percentage of GFP-positive cells. (C) Immnoblots of lysates from DMSO- and TSA-treated cells for AcH3. H3
served as loading control. These data are from a single experiment and are representative of three independent experiments.
Fig. 4. RNAP II and NELF bind to repressed HIV-1 LTR. ChIP assays were performed
to examine RNAP II and NELF binding to the HIV-1 LTR as well as acetylation of
histone H3. These data are from a single experiment performed in triplicate and are
representative of three independent experiments. Bars show average values 7SD,
n¼3. npo0.05 and nnpo0.01 (Student's t test).
Fig. 5. RNAP II pausing occurs in latent cell lines. Latently HIV-1-infected T cell
lines were treated with 2 μg/mL PHA and 10ng/mL PMA for 24 h. Expression of
initiated and elongated HIV-1 was measured by qRT-PCR using primers described
in Methods. These data are from a single experiment performed in triplicate and
are representative of three independent experiments.
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NELF-B to knockdown NELF and determine if this is sufﬁcient for
activating HIV-1 transcription (Fig. 6). Despite our inability to
efﬁciently knock down NELF (Fig. 6C), which was hampered by
toxicity, reﬂecting the importance of this complex in regulating
general transcription, knocking down NELF-B in the absence of any
additional treatment signiﬁcantly induced HIV-1 transcription in
all three lines (Fig. 6A–C). For example, even a depletion of 19%, as
determined by densitometry, of NELF-B induced HIV-1 expression
by 9 fold in BA1 cells (Fig. 6). Similar results were seen using
siRNAs rather than shRNA (data not shown). These data support
Fig. 6. NELF Limits HIV-1 transcription in inducible cells. Cell lines were transduced with sh-Ctrl Vector or sh-NELF-B speciﬁc lentivirus. (A, B) 72 h post-transduction GFP
expression was measured by ﬂow cytometry. (C) The knockdown of NELF-B and induction of HIV-1 was validated by immunoblots for NELF and p24 Gag. These data are from
a single experiment and are representative of three independent experiments.
K. Kaczmarek Michaels et al. / Virology 486 (2015) 7–14 11the conclusion that RNAP II pausing limits HIV-1 transcription
independent of orientation of the HIV-1 provirus and expression
of the endogenous gene and suggest that transcriptional elonga-
tion may be a general mechanism that contributes to the main-
tenance of HIV-1 latency.Discussion
Since HIV-1 has a propensity to integrate into transcriptionally
active genes, transcriptional interference in which a neighboring
promoter represses HIV-1 LTR activity has been suggested as a
common pathway for the establishment and maintenance of
proviral latency. Although several possible mechanisms have been
suggested to be responsible for transcriptional interference such as
RNAP II collisions, competition for key transcription factors and
recruitment of chromatin remodeling factors (Gallastegui et al.,
2011; Lenasi et al., 2008; Schiralli Lester and Henderson, 2012),
whether there are common biochemical processes that lead to the
establishment of latently infected cells is controversial. In this
study we examined three different cell lines which had a single
inducible HIV-1 provirus integrated into actively transcribed host
genes to gain insights into the biochemical processes responsible
for transcriptional interference. We show that induction of HIV-1
expression was not incompatible with transcription of the host
gene and that RNAP II pausing was a checkpoint in all three lines
regardless of the orientation of the HIV-1 LTR to the host gene
promoter.The three lines examined included proviral integrations either
in a parallel or convergent orientation. Although 17 lines have
been examined for orientation of provirus integration, we have not
observed latently infected cell lines with HIV-1 provirus in a
divergent orientation. The endogenous genes in these lines were
all expressed and repression of the endogenous gene following cell
activation was not a general requirement for inducible HIV-1
transcription. This observation would suggest that upstream host
promoters in general are not over-powering or disrupting the
transcriptional machinery of the integrated LTR and that active
transcription is not incompatible with HIV-1 expression. These
results appear to differ from previous studies using cell line
models of latency, which suggest HIV-1 transcriptional activation
requires downregulation of the neighboring host gene (Lenasi
et al., 2008); however, they are consistent with recent experiments
using dual reporter viruses, in which one marker is driven by the
HIV-1 LTR and a second marker is regulated by a constitutive
promoter, where double-positive cells were observed (Calvanese
et al., 2013; Dahabieh et al., 2013). Discrepancies between these
studies may reﬂect differences between cell lines, mediators used
to activate cells or reporter viruses and warrant further investi-
gation of mechanisms of transcriptional interference.
Chromatin does not appear to be the primary mechanism
repressing HIV-1 in these cell lines since two of the three lines are
only partially responsive to treatment with the HDAC inhibitor
TSA. In addition, we observe the presence of acetylated histone H3
associated with the HIV-1 5′ LTR prior to activation in CA5 and BA1
cells. Our results would also be consistent with these proviruses
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thus being in an open chromatin state. It is tempting to speculate
that integration of the HIV-1 provirus into transcriptionally active
genes rather than untranscribed DNA may actually facilitate
reactivation by assisting with the clearing of the LTR of repressive
or chromatin-remodeling factors, and thus assuring open chro-
matin structure (Gallastegui et al., 2011; Lenasi et al., 2008; Marini
et al., 2015). Furthermore, the bias of HIV integrating into tran-
scriptionally active genes and the potential modest inﬂuence of
chromatin in regulating provirus transcription may in part explain
why HDAC inhibitors target only a subset of latently infected cells
and their limited success in clinical trials (Siliciano and Greene,
2011).
Recently, it has been suggested that integration of HIV-1
impacts the expression of the endogenous genes which potentially
contribute to persistence and expansion of HIV-1 infected cells
(Ikeda et al., 2007; Maldarelli et al., 2014). For example, integration
of provirus into introns of BACH2 and MKL2 in the same tran-
scriptional orientation correlated with clonal expansion of infected
cells (Ikeda et al., 2007; Maldarelli et al., 2014). We observed that
integration of provirus resulted in modest increases in the
expression of the endogenous genes, PDZD8 and HELZ, in the BA1
and 11B10 cell lines, respectively. In both of these cell lines pro-
virus was integrated in a convergent orientation and, although we
did not explore the mechanism, it is possible that the HIV LTR in
the converse orientation is altering the local chromatin environ-
ment to promote targeted host gene expression. PDZD8, a moesin-
interacting protein that regulates cytoskeleton organization, has
been shown to inﬂuence herpes simplex virus type 1 and HIV-1
infections (Guth and Sodroski, 2014; Henning et al., 2010). For
HIV-1, PDZD8 enhances infection by interacting with Gag to sta-
bilize HIV-1 capsid and modulating the uncoating process during
reverse transcription (Guth and Sodroski, 2014; Henning et al.,
2010). HELZ is a zinc-ﬁnger containing RNA-helicase important for
global translational initiation (Hasgall et al., 2011). Targeting of
these genes does not appear to present any signiﬁcant growth
advantages and integration into these sites was not over-repre-
sented during the generation of cell lines. However, we cannot rule
out the possibility that there are intrinsic properties that led to
selective advantages for these cell lines during the cloning process.
Regardless, these lines still provide a useful experimental system
to explore how HIV-1 behaves in the context of a transcriptionally
active unit.
RNAP II pausing has been implicated as a mechanisms for
transcriptional interference of coliphage λ and the tandem pro-
moters that encode the mouse gene FPGS (Palmer et al., 2009).
Furthermore, previous studies have indicated that RNAP II pausing
is a key checkpoint that limits HIV-1 transcription in cell line
models of latency as well as primary CD4þ T cells (Feinberg et al.,
1991; Kao et al., 1987; Laspia et al., 1989; Natarajan et al., 2013;
Jadlowsky et al., 2014). Our results demonstrating an abundance of
initiated transcripts relative to fully transcribed HIV-1 mRNA and
an accumulation of RNAP II and NELF at HIV-1 LTR prior to
induction of the HIV-1 provirus are consistent with a model in
which pausing contributes to transcriptional interference of the
HIV-1 LTR. Most importantly, knocking down the NELF complex
which is necessary for RNAP II pausing (Adelman and Lis, 2012) is
sufﬁcient to induce HIV-1 transcription in all three cell lines sug-
gesting that RNAP II pausing is contributing to HIV-1 transcrip-
tional repression in these cell lines.
Taken together, based on the analysis of several cell lines that
harbored inducible latent HIV-1, the orientation of HIV-1 inte-
gration has minimal impact on the repression and reactivation of
HIV-1 provirus. The latently infected T cell lines could all strongly
induce HIV-1 transcription independent of the expression of the
different host genes the provirus was integrated into. Therefore,HIV-1 transcription is not necessarily incompatible with an active
upstream endogenous promoter. More importantly, although it is
unclear as to whether common pathways are responsible for
initially repressing HIV-1 transcription, there is a convergence of
repressive mechanisms on RNAP II processivity suggesting that
this is a common limiting step that maintains HIV-1 latency in
multiple cellular contexts including primary cells (Kaczmarek
Michaels et al., 2015; Natarajan et al., 2013). Exploring agents that
modulate RNAP II processiveness will potentially identify novel
therapeutics against latently infected cells.Materials and methods
Cell culture
Jurkat clone E6-1 was originally purchased from American Type
Culture Collection (ATCC, Manassas, VA). CA5, BA1 and 11B10 are
Jurkat derived lines that harbor a single repressed copy of NLENG,
a recombinant HIV-1-GFP provirus. The selection strategy for these
cell lines has been previously described (Duverger et al., 2009;
Jones et al., 2007). Cells were propagated in RPMI 1640 supple-
mented with 10% fetal bovine serum (FBS), 100 units/ml penicillin,
100 μg/ml streptomycin (P/S), and 0.2 M L-glutamine. For some
experiments cells were activated with 2 μg/mL PHA and 10 ng/mL
PMA or 0.5 μM TSA and harvested 24 h post-stimulation.
Human embryonic kidney 293 T cells (HEK293T) were pur-
chased from ATCC and cultured in Dulbecco's modiﬁed Eagle's
medium containing 10% FBS and P/S. Cells were incubated in a
37 °C humidiﬁed incubator with 5% CO2.
Identiﬁcation of proviral integration sites
Brieﬂy, the proviral integration sites were mapped using a
modiﬁcation of a previously published method (Han et al., 2004)
that combined inverse and nested PCR strategies. Chromosomal
DNA was digested with either PstI, SphI or SpeI. Puriﬁed digested
DNA was then subjected to self-ligation by with T4 ligase. The
ligation product was used as template in an inverse PCR reaction
with primers FW068 (5′-GGTCAGCCAAAATTACCCTATAGTG-3′) and
FW032 (5′-AGTAGCCTTGTGTGTGGTA GAT-3′), which bind in gag
and the viral LTR, respectively, followed by a nested PCR using
primer FW067 (5′-TGTTAAAAGAGACCATCAATGAG-3′) and FW033
(5′-TGGTGTGTA GTTCTGCCAATCA-3′). PCR products were puriﬁed
and subjected to sequencing using primers from the nested PCR
reaction. Only PCR products containing parts of the gag gene and/
or the 5′ end of the viral LTR were considered for mapping proviral
integration sites.
Flow cytometry
Cells were washed with PBS and ﬁxed with 2% paraformalde-
hyde. Fluorescence was measured using Becton Dickinson FACScan
at the Flow Core Facility at Boston University Medical Center and
UAB CFAR Flow Cytometry Core/Joint UAB Flow Cytometry Core.
Transfections, virus generation and infections
NELF shRNA and control scrambled shRNA (OriGene) were
packaged by cotransfecting Tat, RSV-Rev, Gag/Pol and VSV-G into
HEK293T cells using calcium phosphate as previously described
(Natarajan et al., 2013). In addition, shRNA experiments were
validated with siRNA cocktails purchased from Dharmacon. Viru-
ses were collected 48 h post-transfection and ﬁltered through a
Puradisc 25 Syringe Filter with 0.45-μm Polyethersulfone
K. Kaczmarek Michaels et al. / Virology 486 (2015) 7–14 13membrane (Whatman). Jurkat cells were transduced by culturing
with supernatants containing lentiviral constructs for 12–16 h.Quantitative real time-PCR
RNA was prepared by resuspending cells in TRIzol (Life Tech-
nologies), and cDNA was generated using SuperScript II Reverse
Transcriptase (Invitrogen) and random primers (Promega). GoTaq
qPCR Master Mix (Promega) was used for quantitative real-time
PCR reactions. Initiated HIV-1 transcripts (þ1 to þ40) were
ampliﬁed using 5′- GGGTCTCTCTGGTTAGA-3′ and 5′-AGAGCTCC-
CAGGCTCA-3′ primers and elongated HIV-1 transcripts (þ5396 to
þ5531) were ampliﬁed using 5′-GACTAGAGCCCTGGAAGCA-3′ and
5′-GCTTCTTCCTGCCATAGGAG-3′ primers as described previously
(Natarajan et al., 2013). RBM12 transcripts (þ9746 to þ9944)
were ampliﬁed using 5′-GGTGAACTGGGTGAGGCTTT-3′ and 5′-
TACTGGCATTTGCTGGTGGT-3′ primers. HELZ transcripts (þ84,209
to þ95,267) were ampliﬁed using 5′-CCAGCTGCCGCCTGTGCTTA-
3′ and 5′-CACTCCATGGCCTGGGC AGC-3′ primers. PDZD8 tran-
scripts (þ880 to þ957) were ampliﬁed using 5′-AAGGCTGCGC
TTGGTCTTTA-3′ and 5′-AAGTCGATCAGCGGGTCTTC-3′ primers. To
amplify chimeric RBM12 transcripts RBM12 (þ14,769F) 5′-
AGTGCTCGTTGTGGACTGTAAT-3′ and HIV-1 LTR (-346R) 5′-
AGTGCTCGTTGTGGACTGTAAT-3′ primers were used. To amplify
chimeric PDZD8 and HELZ transcripts HIV-1 LTR (-102 F) 5′-
GACTTTCCGCTGGGGACTTTC-3′ and either PDZD8 (þ36,250F) 5′-
ACATTTGTGTCCTTGCTAATGGT-3′ or HELZ (þ96,171) 5′-ACAGT-
GATACAGTGGGTTGCAT-3′ primers were used. β-actin mRNA was
ampliﬁed using a QuantiTect primer assay (Qiagen). PCR was car-
ried out for 45 cycles, and the relative expression was calculated
using the ΔΔCt method (Livak and Schmittgen, 2001), normal-
izing speciﬁc ampliﬁcation of the transcripts of interest to the β-
actin control for each speciﬁc sample.ChIP-qPCR
Chromatin immunoprecpitations were performed as previously
described (Natarajan et al., 2013). Antibodies used were as follows:
anti-NELF-D (Proteintech), anti-RNAP II (Santa Cruz Biotechnol-
ogy), anti-AcH3 (Upstate Biotechnology) and rabbit IgG
(Upstate Biotechnology). Quantitative real-time PCR analysis was
carried out using SYBR green reagents and the primers 5′-
TGCTTTTTGCCTGTACTGGGTCTC-3′ and 5′-GCACACACTACTTGAA-
GCACTCAAG-3′, which amplify the 14 to þ113 region of HIV-1
LTR.Immunoblot analysis
Whole-cell lysates were prepared by washing cells with cold
PBS and lysing with buffer containing 10 mM Tris–Cl (pH 7.4),
150 mM NaCl, 1.0 mM EDTA (pH 8.0), 2.0 mM sodium vanadate,
10 mM sodium ﬂuoride, 10 mM sodium pyrophosphate, 1% Triton
X-100, 1.0 mM phenylmethylsulfonyl ﬂuoride, and protease inhi-
bitor mixture III (Calbiochem). Protein was measured using the
BSA assay (Pierce). Samples were heated for 5 min at 100 °C before
loading onto a 10% SDS-PAGE gel. Proteins were transferred from
the PAGE to a polyvinylidene diﬂuoride membrane (Millipore) by
electroblotting. Antibodies used were as follows: anti-AcH3
(Upstate Biotechnology), anti-H3 (Abcam), anti-NELF-B (kind gift
from Dr. Rong Li (University of Virginia)), anti-β-actin (Sigma-
Aldrich) and anti-HIV-1 p24 (3537; NIH AIDS Research and
Reference Reagent Program).Statistical analysis
Statistical analysis was carried out using Student t test. A two-
tailed distribution was performed on paired samples. Values of
o0.01 were considered signiﬁcant.Acknowledgments
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